Sign up to save your podcasts
Or
Share JAMA Oncology : High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
JAMA Oncology : High TMB in NSCLC and Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade
Interview with Mark M. Awad, MD, PhD, author of Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Hosted by Jack West, MD.
View all episodes
By The JAMA Network
4.9
1212 ratings
Interview with Mark M. Awad, MD, PhD, author of Association of High Tumor Mutation Burden in Non–Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression Levels. Hosted by Jack West, MD.
More shows like JAMA Network
View all
Science Magazine Podcast
806 Listeners
JAMA Editors' Summary
129 Listeners
HBR IdeaCast
220 Listeners
NEJM This Week
315 Listeners
JAMA Author Interviews
165 Listeners
JAMA Clinical Reviews
483 Listeners
AFP: American Family Physician Podcast
682 Listeners
JAMA Pediatrics Editors' Summary
37 Listeners
Frankly Speaking About Family Medicine
256 Listeners
The Curbsiders Internal Medicine Podcast
3,329 Listeners
JAMA Internal Medicine Author Interviews
18 Listeners
JAMA Neurology Author Interviews
14 Listeners
JAMA Psychiatry Author Interviews
24 Listeners
JAMA Surgery Author Interviews
6 Listeners
JAMA Medical News
88 Listeners
The Indicator from Planet Money
9,532 Listeners
Annals On Call Podcast
181 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
321 Listeners
Cardionerds: A Cardiology Podcast
411 Listeners
JAMAevidence JAMA Guide to Statistics and Methods
18 Listeners
AMA Update
93 Listeners
NEJM AI Grand Rounds
51 Listeners